Naresh Jha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Naresh Jha has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Hadi Seikaly
Department of Surgery, Division of Otolaryngology, University of Alberta, Edmonton, Alberta, Canada
3 shared publicationsCiaran McNamee
Department of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada
1 shared publicationDavid Williams
Department of Surgery, Division of Head and Neck Surgery, University of Alberta, Edmonton, Alberta, Canada
1 shared publicationDonna Sutherland
Department of Surgical Oncology, Cancer Care Manitoba, University of Manitoba, Winnipeg, Manitoba, Canada
1 shared publicationElizabeth A. Barnes
Department of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada
1 shared publication- Hadi Seikaly
Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada
1 shared publication
Latest Publications
- 23 December 2008
- Published by Wiley in Head & Neck
- Vol. 31 (2) , 234-243
Phase III randomized study: Oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation‐induced xerostomia
Background.: Xerostomia is a serious morbidity of radiation treatment in head and neck cancer.Methods.: We conducted a prospective phase III multicenter randomized study comparing submandibular salivary gland transfer (SGT) procedure with pilocarpine during and for 3 months after XRT. Salivary flow (baseline, stimulated) and University of Washington Quality of Life Questionnaire (U of W QOL) scores were measured.Results.: An interim intent to treat analysis (120 patients) at 6 months shows superior results in SGT arm: median baseline salivary flow for SGT (0.04 mL/minute) versus pilocarpine (0.01 mL/minute), p = .001; median stimulated salivary flow (0.18 mL/minute) for SGT versus (0.05 mL/minute) for pilocarpine, p = .003. Scores (U of W QOL) for amount (p = .017) and consistency of saliva (p = .005) in favor of SGT leading to premature closure of study.Conclusions.: Submandibular SGT procedure is superior to pilocarpine in management of radiation‐induced xerostomia. © 2008 Wiley Periodicals, Inc. Head Neck, 2009
- 23 December 2008
- Published by Wiley in Head & Neck
- Vol. 31 (2) , 234-243
Phase III randomized study: Oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation‐induced xerostomia
Background.: Xerostomia is a serious morbidity of radiation treatment in head and neck cancer.Methods.: We conducted a prospective phase III multicenter randomized study comparing submandibular salivary gland transfer (SGT) procedure with pilocarpine during and for 3 months after XRT. Salivary flow (baseline, stimulated) and University of Washington Quality of Life Questionnaire (U of W QOL) scores were measured.Results.: An interim intent to treat analysis (120 patients) at 6 months shows superior results in SGT arm: median baseline salivary flow for SGT (0.04 mL/minute) versus pilocarpine (0.01 mL/minute), p = .001; median stimulated salivary flow (0.18 mL/minute) for SGT versus (0.05 mL/minute) for pilocarpine, p = .003. Scores (U of W QOL) for amount (p = .017) and consistency of saliva (p = .005) in favor of SGT leading to premature closure of study.Conclusions.: Submandibular SGT procedure is superior to pilocarpine in management of radiation‐induced xerostomia. © 2008 Wiley Periodicals, Inc. Head Neck, 2009
- 16 April 2002
- Vol. 15 (2) , 139-44
Speech outcomes in patients rehabilitated with maxillary obturator prostheses after maxillectomy: a prospective study.
Speech outcome measurements are valuable in guiding treatment and determining the effectiveness of rehabilitation with a maxillary obturator prosthesis in individuals with palatal resection. Although speech outcome data exist in the literature for such patients, relatively few reports have used clinical tools designed to measure the acoustic, physiologic, and perceptual bases of speech. This investigation reports these measures for individuals rehabilitated with a maxillary obturator. Speech measurements were collected prospectively at three clinical visit times (preoperative, postresection without an obturator, and with a definitive obturator) for 12 patients assigned to three groups based on the extent of their resection (< half the hard palate, > or = half the hard palate, hard and soft palates). Acoustic data were obtained with the Nasometer, aeromechanical data were collected with the PERCI-SARS, and perceptual ratings of speech intelligibility were obtained through listener analysis. Significant differences existed among the three treatments for all dependent variables and revealed that speech without an obturator is significantly different from the preoperative state, while speech with an obturator does not differ significantly from preoperative function. Individuals with soft palate involvement exhibited significantly poorer nasalance values than individuals with involvement of the hard palate only. Rehabilitation with a maxillary obturator is successful in restoring preoperative speech function. Rehabilitation of individuals with involvement of the soft palate may be more challenging.
- 16 April 2002
- Vol. 15 (2) , 139-44
Speech outcomes in patients rehabilitated with maxillary obturator prostheses after maxillectomy: a prospective study.
Speech outcome measurements are valuable in guiding treatment and determining the effectiveness of rehabilitation with a maxillary obturator prosthesis in individuals with palatal resection. Although speech outcome data exist in the literature for such patients, relatively few reports have used clinical tools designed to measure the acoustic, physiologic, and perceptual bases of speech. This investigation reports these measures for individuals rehabilitated with a maxillary obturator. Speech measurements were collected prospectively at three clinical visit times (preoperative, postresection without an obturator, and with a definitive obturator) for 12 patients assigned to three groups based on the extent of their resection (< half the hard palate, > or = half the hard palate, hard and soft palates). Acoustic data were obtained with the Nasometer, aeromechanical data were collected with the PERCI-SARS, and perceptual ratings of speech intelligibility were obtained through listener analysis. Significant differences existed among the three treatments for all dependent variables and revealed that speech without an obturator is significantly different from the preoperative state, while speech with an obturator does not differ significantly from preoperative function. Individuals with soft palate involvement exhibited significantly poorer nasalance values than individuals with involvement of the hard palate only. Rehabilitation with a maxillary obturator is successful in restoring preoperative speech function. Rehabilitation of individuals with involvement of the soft palate may be more challenging.
- 7 June 2000
- Published by Wiley in Head & Neck
- Vol. 22 (4) , 435-438
Subglottic stenosis secondary to extramedullary hematopoiesis in a patient with postpolycythemia myeloid metaplasia
Background Extramedullary hematopoiesis (EMH) is known to occur in myeloproliferative disorders and hemoglobinopathies and is usually seen in the spleen and liver. Methods We report the first case of EMH causing subglottic stenosis in a woman with postpolycythemia myeloid metaplasia (PPMM). A tracheotomy was performed to maintain the airway and local radiotherapy was given. Results Two months after the radiotherapy was completed laryngoscopy showed an unobstructed airway with no evidence of disease, and the patient was successfully decanulated. Magnetic resonance imaging 8 months after radiotherapy confirmed the absence of local disease. Conclusion Consideration should be given to EMH as a possible cause of airway obstruction in the differential diagnosis of a patient with a history of PPMM. © 2000 Wiley & Son, Inc. Head Neck 22: 435–438, 2000.
- 7 June 2000
- Published by Wiley in Head & Neck
- Vol. 22 (4) , 435-438
Subglottic stenosis secondary to extramedullary hematopoiesis in a patient with postpolycythemia myeloid metaplasia
Background Extramedullary hematopoiesis (EMH) is known to occur in myeloproliferative disorders and hemoglobinopathies and is usually seen in the spleen and liver. Methods We report the first case of EMH causing subglottic stenosis in a woman with postpolycythemia myeloid metaplasia (PPMM). A tracheotomy was performed to maintain the airway and local radiotherapy was given. Results Two months after the radiotherapy was completed laryngoscopy showed an unobstructed airway with no evidence of disease, and the patient was successfully decanulated. Magnetic resonance imaging 8 months after radiotherapy confirmed the absence of local disease. Conclusion Consideration should be given to EMH as a possible cause of airway obstruction in the differential diagnosis of a patient with a history of PPMM. © 2000 Wiley & Son, Inc. Head Neck 22: 435–438, 2000.
- 1 January 2000
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 46 (1) , 7-11
Submandibular salivary gland transfer prevents radiation-induced xerostomia
- 1 January 2000
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 46 (1) , 7-11
Submandibular salivary gland transfer prevents radiation-induced xerostomia
- 1 March 1999
- Published by Wiley in Journal of Surgical Oncology
- Vol. 70 (3) , 194-198
Primary pericardial synovial sarcoma: A case report and literature review
Primary synovial sarcoma of the heart is a rare tumor, with only six previous cases having been reported in the literature. Treatment has included surgery with or without chemotherapy. We present the first case of a documented synovial sarcoma arising from the pericardium in a 19-year-old man. Molecular analysis for t(X;18) SYT-SSX gene fusion was positive. Radiation treatment was given postoperatively to the entire heart with a boost to the area where the margins were positive. J. Surg. Oncol. 1999;70:194–198.
- 1 March 1999
- Published by Wiley in Journal of Surgical Oncology
- Vol. 70 (3) , 194-198
Primary pericardial synovial sarcoma: A case report and literature review
Primary synovial sarcoma of the heart is a rare tumor, with only six previous cases having been reported in the literature. Treatment has included surgery with or without chemotherapy. We present the first case of a documented synovial sarcoma arising from the pericardium in a 19-year-old man. Molecular analysis for t(X;18) SYT-SSX gene fusion was positive. Radiation treatment was given postoperatively to the entire heart with a boost to the area where the margins were positive. J. Surg. Oncol. 1999;70:194–198.